ABCC4 and neuroblastoma: HepG2 cells transfected with the human ABCC4 plasmid showed enhanced resistance to irinotecan, topotecan, and cyclophosphamide, all of which are used in neuroblastoma treatment or are in trial for use (Langler et al., 2002; Kushner et al., 2006; London et al., 2010).